FdaApplication
NDA 211530
Identifiers
- fda_app_no: NDA211530
Properties
| Property | Value |
|---|---|
| applicant_name | HOSPIRA INC |
| application_type | NDA |
| approval_date | 2022-12-15 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | 25MG/ML (25MG/ML) | SOLUTION;INTRAVENOUS |
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | 200MG/8ML (25MG/ML) | SOLUTION;INTRAVENOUS |
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | 100MG/4ML (25MG/ML) | SOLUTION;INTRAVENOUS |
3 products